Search results
AEDs in Stadiums
Author(s):
Mario D Bassi
,
Juan M Farina
,
Jorge Bombau
,
et al
Added:
1 year ago
Article
Daniel JFM Thuijs
Author
Author(s):
Neil T Srinivasan
,
Richard Schilling
Added:
3 years ago
An estimated 180,000–300,000 sudden cardiac deaths (SCD) occur in the US annually.1,2 Worldwide, sudden and unexpected cardiac death is the most common cause of death,2 accounting for 17 million deaths every year with SCD accounting for 25% of these. The accepted definition of SCD is death that occurs within one hour of onset of symptoms in witnessed cases, and within 24 hours of last being seen…
View more
Author(s):
Demosthenes G Katritsis
,
Bernard J Gersh
,
A John Camm
Added:
3 years ago
Sudden cardiac death (SCD) is usually defined as death due to cardiac causes occurring within 1 hour of the onset of symptoms. Unexplained sudden death occurring in an individual older than 1 year of age is known as 'sudden unexplained death syndrome'. Unexplained sudden death occurring in an individual younger than 1 year of age is known as 'sudden unexplained death in infancy'. SCD with…
View more
Author(s):
Deepika Narasimha
,
Anne B Curtis
Added:
3 years ago
Implantable cardiac devices such as implantable cardioverter- defibrillators (ICDs) and cardiac resynchronisation therapy (CRT) devices lead to improved survival and better clinical outcomes in appropriately selected patients with heart failure (HF) with a reduced ejection fraction (EF). Although there are significant sex differences in the aetiology, pathophysiology and clinical course of HF,…
View more
Author(s):
David J Callans
,
Matthew Reynolds
,
Peter J Zimetbaum
Added:
3 years ago
There was a joke years ago that no one understood electrophysiologists, or even wanted to, and that suited us just fine. We were happy to be isolated in our labs working on largely academic problems. Fast forward to now, and the monumental advances in our ability to map and ablate arrhythmias and in new strategies for implantable device therapy have thrust us into the realm of high-volume…
View more
Author(s):
Jackson J Liang
,
Pasquale Santangeli
,
David J Callans
Added:
3 years ago
Ventricular tachycardia (VT) is a significant cause of morbidity and mortality in patients with structural heart disease (SHD). While implantable cardioverter-defibrillators (ICDs) have been shown to be effective in preventing sudden death due to ventricular arrhythmias, they are not able to prevent recurrent VT episodes. Antiarrhythmic drugs (AADs) have some demonstrated efficacy in preventing…
View more
Howard Chen
Job title: Tufts Medical Center, Boston, MA, US
Author
Author(s):
Giulio Falasconi
Added:
2 days ago
EHRA 24 - In this video, investigator, Dr Giulio Falasconi (Humanitas Research Hospital, IT) joins us to discuss the findings from the QDOT-by-LAWT trial. This study included 162 patients with paroxysmal atrial fibrillation not responding to antiarrhythmic drugs. They were retrospectively enrolled and randomized on a 1:1 basis to the QDOT-by-LAWT study group, and the control group.Findings showed…
View more
Author(s):
Pasquale Santangeli
,
Luigi Di Biase
,
Eloisa Basile
,
et al
Added:
3 years ago
The number of invasive electrophysiological procedures is steadily increasing in Western countries, as techniques advance and the age of the population increases. Gender exerts a profound influence on the epidemiology, pathophysiology and clinical presentation of many cardiac rhythm disorders, and all these factors may affect the outcome of invasive electrophysiological procedures. Disturbingly,…
View more